Tereza Vaclová

409 total citations
12 papers, 205 citations indexed

About

Tereza Vaclová is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Tereza Vaclová has authored 12 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Tereza Vaclová's work include DNA Repair Mechanisms (5 papers), BRCA gene mutations in cancer (4 papers) and CRISPR and Genetic Engineering (3 papers). Tereza Vaclová is often cited by papers focused on DNA Repair Mechanisms (5 papers), BRCA gene mutations in cancer (4 papers) and CRISPR and Genetic Engineering (3 papers). Tereza Vaclová collaborates with scholars based in United States, Spain and United Kingdom. Tereza Vaclová's co-authors include Nicholas T. Woods, Miguel Urioste, Marcelo A. Carvalho, David E. Goldgar, Álvaro N.A. Monteiro, Volha A. Golubeva, Rebekah Baskin, Ana Osório, Edwin S. Iversen and Fergus J. Couch and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Tereza Vaclová

12 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tereza Vaclová United States 8 132 74 61 57 40 12 205
Mahbubl Ahmed United Kingdom 6 128 1.0× 86 1.2× 70 1.1× 56 1.0× 73 1.8× 13 232
Filip Lhota Czechia 9 111 0.8× 74 1.0× 43 0.7× 18 0.3× 44 1.1× 11 185
Elodie Noël United Kingdom 6 139 1.1× 26 0.4× 57 0.9× 37 0.6× 47 1.2× 6 203
Hermioni Zouridis United States 4 253 1.9× 34 0.5× 61 1.0× 43 0.8× 60 1.5× 5 312
Francesc Muyas United Kingdom 8 115 0.9× 50 0.7× 40 0.7× 29 0.5× 97 2.4× 16 204
Adrien Buisson France 6 73 0.6× 56 0.8× 94 1.5× 34 0.6× 38 0.9× 16 151
S. Christova Bulgaria 7 131 1.0× 42 0.6× 54 0.9× 48 0.8× 101 2.5× 7 224
Manuel Krispin Germany 7 210 1.6× 24 0.3× 67 1.1× 54 0.9× 90 2.3× 8 287
Eric J. Schafer United States 3 124 0.9× 34 0.5× 55 0.9× 43 0.8× 40 1.0× 4 187
Ewa A. Bergmann United States 3 98 0.7× 48 0.6× 40 0.7× 22 0.4× 77 1.9× 3 177

Countries citing papers authored by Tereza Vaclová

Since Specialization
Citations

This map shows the geographic impact of Tereza Vaclová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tereza Vaclová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tereza Vaclová more than expected).

Fields of papers citing papers by Tereza Vaclová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tereza Vaclová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tereza Vaclová. The network helps show where Tereza Vaclová may publish in the future.

Co-authorship network of co-authors of Tereza Vaclová

This figure shows the co-authorship network connecting the top 25 collaborators of Tereza Vaclová. A scholar is included among the top collaborators of Tereza Vaclová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tereza Vaclová. Tereza Vaclová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Grazini, Ursula, Aleksandra Markovets, Lucy Ireland, et al.. (2024). Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non–Small Cell Lung Cancer with PIK3CA/PTEN Alterations. Clinical Cancer Research. 30(18). 4143–4154. 12 indexed citations
3.
Vaclová, Tereza, Atanu Chakraborty, James Sherwood, et al.. (2022). Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition. Scientific Reports. 12(1). 2699–2699. 8 indexed citations
4.
Vaclová, Tereza, Ursula Grazini, Lewis S. C. Ward, et al.. (2021). Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers. Nature Communications. 12(1). 1780–1780. 46 indexed citations
5.
Verlande, Amandine, Tereza Vaclová, Miroslava Sedláčková, et al.. (2020). Dual Targeting of BRAF and mTOR Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds. Cancers. 12(6). 1516–1516. 10 indexed citations
6.
Benitéz‐Buelga, Carlos, Tereza Vaclová, María Victoria Fernández, et al.. (2017). Genetic variation in the NEIL2 DNA glycosylase gene is associated with oxidative DNA damage in BRCA2 mutation carriers. Oncotarget. 8(70). 114626–114636. 14 indexed citations
7.
Vaclová, Tereza, Sarah Maguire, Matthew Pugh, Peter Barry, & Nick Orr. (2017). Abstract 816: Molecular and genomic characterization of a newly established male breast cancer cell line. Cancer Research. 77(13_Supplement). 816–816. 3 indexed citations
8.
Woods, Nicholas T., Rebekah Baskin, Volha A. Golubeva, et al.. (2016). Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. npj Genomic Medicine. 1(1). 65 indexed citations
9.
Vaclová, Tereza, Nicholas T. Woods, Diego Megı́as, et al.. (2016). Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect. Human Molecular Genetics. 25(24). ddw343–ddw343. 5 indexed citations
10.
Benitéz‐Buelga, Carlos, Tereza Vaclová, Miguel Urioste, et al.. (2016). Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers. Oncotarget. 7(18). 25815–25825. 14 indexed citations
11.
Vaclová, Tereza, Gonzalo Goméz-López, Fernando Setién, et al.. (2015). DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers. Breast Cancer Research and Treatment. 152(2). 271–282. 24 indexed citations
12.
Vaclová, Tereza, Roger L. Milne, Laura Saucedo-Cuevas, et al.. (2012). Abstract 90: An evaluation of the genes involved in the Base Excision Repair (BER) pathway as potential phenotypic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.. Cancer Research. 72(8_Supplement). 90–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahbubl Ahmed Breakdown of academic impact, for papers by Filip Lhota Breakdown of academic impact, for papers by Elodie Noël Breakdown of academic impact, for papers by Hermioni Zouridis Breakdown of academic impact, for papers by Francesc Muyas Breakdown of academic impact, for papers by Adrien Buisson Breakdown of academic impact, for papers by S. Christova Breakdown of academic impact, for papers by Manuel Krispin Breakdown of academic impact, for papers by Eric J. Schafer Breakdown of academic impact, for papers by Ewa A. Bergmann
Rankless by CCL
2026